Results 121 to 130 of about 3,726 (180)

Real-World Benefit of Tildrakizumab for Moderate-to-Severe Plaque Psoriasis: Findings from a Systematic Literature Review and Meta-Analysis. [PDF]

Dermatol Ther (Heidelb)
Gottlieb S, Farberg AS, Bhatia N, Fazeli MS, Hofer K, Lam O, Barghout V, Mathew J, Ferro TJ.   +8 more
europepmc   +1 more source

New-onset ulcerative colitis temporally associated with with ixekizumab in a psoriasis patient successfully treated with guselkunmab: A case report. [PDF]

Medicine (Baltimore)
Tang J, Li W, Zhang H.
europepmc   +1 more source

Extrapolating Guselkumab Efficacy to Juvenile Psoriatic Arthritis from Adult Psoriatic Arthritis and Adult and Pediatric Psoriasis Data. [PDF]

Paediatr Drugs
Crauwels H, Ringold S, Howard S, Van Hartingsveldt B, Smith V, Jett M, Baguet T, Adamson E, Chakravarty SD, Leu JH.   +9 more
europepmc   +1 more source

Super responders to biologic therapy in psoriasis: definitions, predictors, and implications for precision medicine. [PDF]

Front Immunol
Peng X, Wang Z, Han K.
europepmc   +1 more source

Efficacy of tofacitinib in the treatment of refractory palmoplantar psoriasis (non-pustular): case report and literature review. [PDF]

An Bras Dermatol
Sakiyama PH, Miot LDB, Miot HA.
europepmc   +1 more source

Efficacy and safety of IL-23p19 and IL-12/23p40 inhibitors in moderate-to-severe Crohn's disease: a systematic review and network meta-analysis. [PDF]

Ann Med
Kaneko M, Sakuraba A.
europepmc   +1 more source

Long-Term Impact of Guselkumab on Systemic Inflammation Indices in Moderate-to-Severe Psoriasis. [PDF]

J Clin Med
Mortato E, Marcelli L, Panichelli A, Talamonti M, Gneo V, Marrapodi D, Di Raimondo C, Bianchi L, Galluzzo M.   +8 more
europepmc   +1 more source

Relative Efficacy of Immunomodulatory Monotherapies for Psoriasis of the Scalp: A Network Meta-Analysis Study. [PDF]

J Cosmet Dermatol
Gupta AK, Bamimore MA, Wang T, Piguet V, Talukder M.   +4 more
europepmc   +1 more source

Cutaneous and Genitalia Inflammation Treated With Guselkumab and Antimicrobial Therapy in a Patient with a History of Crohn's Disease. [PDF]

ACG Case Rep J
Nikzad N, Khadilkar S, Onajin Darkwa O, Mann Gradwohl K, Chadha AA, Pekow J, Rubin DT.   +6 more
europepmc   +1 more source

Severe Delayed Hypersensitivity Reaction at Guselkumab Injection Site. [PDF]

Contact Dermatitis
Allichon S, Litovsky J, Sanchez M, Girard C, Granier G, Durand L, Henrion M, Philibert C, Le Souder C, Raison-Peyron N.   +9 more
europepmc   +1 more source